PRESS RELEASE published on 08/13/2025 at 07:00, 8 months 30 days ago Evotec SE reports H1 2025 results: Strong progress on strategy execution Evotec SE reports strong progress on strategy execution with H1 2025 results, showcasing sustainable profitable growth and key collaborations with BMS and Sandoz Evotec SE Growth Collaborations Strategy Execution H1 2025 Results
BRIEF published on 08/06/2025 at 09:57, 9 months 6 days ago Evotec SE publiera ses résultats du premier semestre 2025 Résultats Semestriels Evotec SE Conférence Téléphonique Sciences De La Vie Découverte De Médicaments
BRIEF published on 08/06/2025 at 09:57, 9 months 6 days ago Evotec SE to Release First Half-Year Results 2025 Conference Call Drug Discovery Life Sciences Evotec SE Half-year Results
PRESS RELEASE published on 08/06/2025 at 09:52, 9 months 6 days ago Evotec SE to announce first half-year results 2025 on 13 August 2025 Evotec SE to announce first half-year results for 2025 on 13 August 2025 with a conference call to discuss performance. Company focuses on drug discovery and development Conference Call Drug Discovery Evotec SE Half-year Results AI-driven Innovation
BRIEF published on 07/30/2025 at 07:21, 9 months 13 days ago Evotec et Sandoz renforcent leur partenariat avec la vente potentielle du site de Toulouse Evotec SE Partenariat Stratégique Fabrication De Produits Biologiques Sandoz AG Modèle Allégé En Actifs
BRIEF published on 07/30/2025 at 07:21, 9 months 13 days ago Evotec and Sandoz Advance Partnership with Potential Toulouse Site Sale Strategic Partnership Evotec SE Biologics Manufacturing Sandoz AG Asset-Lighter Model
BRIEF published on 07/30/2025 at 07:19, 9 months 13 days ago Evotec SE et Sandoz AG envisagent de vendre leurs activités – Site d'Evotec Biologics à Toulouse Evotec SE Conditions De Transaction Sandoz AG Vente De Produits Biologiques Site De Toulouse
BRIEF published on 07/30/2025 at 07:19, 9 months 13 days ago Evotec SE and Sandoz AG to Potentially Sell Just – Evotec Biologics Toulouse Site Evotec SE Transaction Terms Sandoz AG Biologics Sale Toulouse Site
PRESS RELEASE published on 07/30/2025 at 07:16, 9 months 13 days ago Evotec and Sandoz evolve their strategic partnership and agree on potential sale of Just – Evotec Biologics Toulouse site Evotec and Sandoz agree on potential sale of Just – Evotec Biologics Toulouse site in strategic partnership evolution Strategic Partnership Sale Evotec Sandoz Biologics
PRESS RELEASE published on 07/30/2025 at 07:14, 9 months 13 days ago EQS-Adhoc: Evotec SE and Sandoz AG planning potential sale of Just – Evotec Biologics Toulouse site Evotec SE and Sandoz AG plan potential sale of Just - Evotec Biologics Toulouse site for $300m in cash with additional technology related consideration. Evotec to retain economic upside Evotec SE Sale Just - Evotec Biologics Toulouse Sandoz AG
Published on 05/13/2026 at 00:00, 2 hours 48 minutes ago Onco-Innovations Announces Initiation of Research Collaboration within PROmAI
Published on 05/12/2026 at 23:35, 3 hours 13 minutes ago Infield Minerals Closes $1.25 Million Financing
Published on 05/12/2026 at 21:55, 4 hours 53 minutes ago UraniumX Discovery Corp Announces Option Agreement with Gold'n Futures
Published on 05/12/2026 at 21:42, 5 hours 6 minutes ago Kidoz Inc. to Present at Planet MicroCap Las Vegas 2026
Published on 05/12/2026 at 14:30, 12 hours 18 minutes ago Pathfinder Ventures Inc. Announces Conclusion of Financing and Intention to Launch New Private Placement
Published on 05/12/2026 at 23:47, 3 hours 1 minute ago Nebius welcomes Clarifai’s core team and licenses inference IP to strengthen Nebius Token Factory
Published on 05/12/2026 at 22:25, 4 hours 23 minutes ago Evotec SE Successfully Placed €116.1 Million Convertible Bonds
Published on 05/12/2026 at 20:21, 6 hours 27 minutes ago Nebius breaks ground on gigawatt-scale AI factory in Independence, Missouri
Published on 05/12/2026 at 19:35, 7 hours 13 minutes ago AUSTRIACARD HOLDINGS AG: Q1 2026 Financial Results
Published on 05/12/2026 at 19:35, 7 hours 13 minutes ago 2026 Annual General Meeting: Strong vote by shareholders in favour of continuity in leadership and strategy
Published on 05/12/2026 at 18:15, 8 hours 33 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 30/04/2026
Published on 05/12/2026 at 18:15, 8 hours 33 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 30/04/2026
Published on 05/12/2026 at 18:10, 8 hours 38 minutes ago imerys-12-05-2026-communiqué-compte-rendu-de-l-assemblée-générale-ordinaire-du-12-mai-2026
Published on 05/12/2026 at 18:10, 8 hours 38 minutes ago imerys-12-05-2026-press-release-summary-of-the-ordinary-shareholders-general-meeting-12-may-2026
Published on 05/12/2026 at 17:50, 8 hours 58 minutes ago Damartex fait évoluer sa gouvernance et engage une réflexion stratégique autour de ses activités
